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ABSTRACT
Diet is amodiﬁable factor that can aﬀect bone strength and integrity, and the risk of fractures. Currently, a hierarchy of scientiﬁc evidence contributes
to our understanding of the role of diet on bone health and fracture risk. The strength of evidence is generally based on the type of study conducted,
the quality of themethodology employed, the rigor and integrity of the data collected and analysis plan, and the transparency and completeness of
the results. Randomized controlled trials (RCTs) are considered tobe thegold standard froma clinical researchparadigm, but there is a dearth of high-
quality diet-related intervention trials with bone as the primary outcome, forcing the use of observational research to inform research and clinical
practices. However, for observational research to be of the most utility, standardization and optimization of the study design, accurate and reliable
measurement of key variables, and appropriate data analysis and data reporting are paramount. Although there have been recommendations
made in relation to RCTs in the ﬁeld of nutrition, no clear rubric exists for best practices in conducting observational research with regard to
nutrition and bone health. Therefore, the purpose of this paper is to describe the best practices and considerations for designing, conducting,
analyzing, interpreting, and reporting observational research speciﬁcally for understanding the role of nutrition in bone health, amassed by a
global panel of scientiﬁc experts with strengths in bone, nutrition epidemiology, physical activity, public health, clinical and translational trials,
and observational study methods. The global panel of scientiﬁc experts represents the leadership and selected participants from the 10th annual
International Symposium for the Nutritional Aspects of Osteoporosis. The topics selected and best practices presented reﬂect expert opinion and
areas of scientiﬁc expertise of the authors rather than a systematic or comprehensive literature review or professional reporting guidelines. Adv
Nutr 2019;10:391–409.
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Introduction
Bone is a dynamic tissue in which a range of modifiable
lifestyle factors, including diet, can affect strength and
integrity, and therefore, the risk of bone fractures (1–3).
Currently, a hierarchy of scientific evidence contributes to
our understanding of the role of diet on bone health and
fracture risk. The strength of evidence is generally based on
the type of study conducted, the quality of the methodology
employed, rigor and integrity of the data collected, appropri-
ate analysis plan, and transparency and completeness of the
results presented in the scientific literature.
Randomized controlled trials (RCTs) are considered to
be the gold standard from a clinical research paradigm (4),
but there is a dearth of high-quality diet-related intervention
trials with bone as the primary outcome (1, 5). There are a
number of factors that make RCTs of dietary interventions
with health-related outcomes (including bone) challenging
to conduct and interpret, including the cost, the time
commitment and difficulties with maintaining adherence
to a given dietary protocol, health problems or medication
changes, and ethical issues associated with assigning people
to a nonintervention control comparison group (6). For trials
with bone as an outcome, a long-term follow-up is typically
required because the entire bone remodeling cycle typically
takes around 6–9 mo. Furthermore, many trials suffer from
limited external validity given that they generally focus on
Copyright C© American Society for Nutrition 2019. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License
(http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For
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homogeneous groups, which is, however, purposeful to gain
a greater understanding of the mechanisms and biological
events or outcomes. Another major challenge with dietary
interventions is that it is often difficult to use a true placebo-
controlled design, because the absence of nutrition is not a
practical study arm and blinding of participants is difficult or
impossible to achieve.When RCT data are not available, data
from observational studies are often used to inform research
and clinical practice, but observational data suffer from a lack
of causal inference. Nevertheless, observational research is
suitable for nutrition and health research because individuals
can be followed for longer periods, permitting researchers
to observe usual dietary practices and health exposures, but
have varying degrees of limitations in their design, methods,
and interpretability of data.
Because age-related changes in bone typically occur slowly
over time, the nature of observational studies are well suited
for evaluating the role of lifestyle effects on bone (7). Well-
designed observational studies have provided a tremendous
amount of information to tailor public health messaging
to reduce bone loss and reduce fracture risk. However,
for this research to be of most utility, standardization and
optimization of the research is paramount. Although there
have been research recommendations made in relation to
RCTs in the field of nutrition (8) and for reporting of studies
in nutritional epidemiology (9, 10), none are specific to
bone as a health outcome. Therefore, the purpose of this
paper is to describe the best practices and considerations for
designing, conducting, analyzing, interpreting, and reporting
observational research specifically for understanding the
role of nutrition in bone health amassed by a global
panel of scientific experts with strengths in bone, nutrition
epidemiology, physical activity, public health, clinical and
translational trials, and observational study methods.
Methods
Observational studies for the purpose of this review included
prospective and retrospective cohorts, cross-sectional, and
case-control studies. Clinical trials were used as a reference,
but were not specifically addressed. The global panel of
scientific experts represented the leadership and selected
participants from the 10th annual International Sympo-
sium for the Nutritional Aspects of Osteoporosis (ISNAO)
meeting in Hong Kong in November of 2017. ISNAO is a
meeting that represents the scientific work from a group of
Supported by a grant to CMW from the Dairy Research Consortium [Dairy Farmers of Canada,
Centre national interprofessionnel de l’économie laitière (CNIEL), National Dairy Council, Dairy
Australia Ltd., Dutch Dairy Association, Danish Dairy Research Foundation], who did not
intervene in data analysis, interpretation or conclusions. Although not related to this
manuscript, Dr. Bailey’s complete funding history can be found at
https://nutritionepidemiology.blogspot.com/.
Address correspondence to RLB (e-mail: reganbailey@purdue.edu).
Abbreviations used: 25(OH)D, serum 25-hydroxy-vitamin D; aBMD, areal bone mineral density;
BMC, bone mineral content; BMD, bone mineral density; BTM, bone turnover markers; CTX,
C-terminal crosslinking telopeptides; FRAX, fracture risk assessment tool; HAL, hip axis length;
ISCD, The International Society for Clinical Densitometry; ISNAO, International Symposium for
the Nutritional Aspects of Osteoporosis; P1CP, 1 C-terminal propeptide; P1NP, procollagen 1
N-terminal propeptide; pQCT, peripheral quantitative computed tomography; QUS,
quantitative ultrasonometry; RCT, randomized controlled trial; vBMD, volumetric BMD.
physician, clinician, academic, and government researchers
who specialize in the role of nutrition and bone health.
The topics selected and best practices presented in this
work reflect expert opinion and areas of scientific expertise
of the authors rather than a systematic or comprehensive
literature review or professional reporting guidelines. The
panel of experts was selected by the organizers of the
ISNAO meeting: Drs. Weaver, Daly, and Bischoff-Ferrari.
Initial meetings to describe the scope of the project and
delineate writing roles were held via conference call and
culminated in a writing meeting held in Hong Kong. It
should be noted that authoritative recommendations for
observational research reporting should also be considered
and applied, including but not limited to the Strengthening
the Reporting of Observational Studies in Epidemiology
(11) and the Strengthening the Reporting of Observational
Studies in Epidemiology for use in nutrition epidemiology
(10).
Pertinent Factors for Consideration in the
Research Design Phase
The first step in any study is to clearly specify the research
question and then to design a study or utilize an existing data
source to address the research question. In establishing or
utilizing an existing data source, it is important to understand
and document how the sample or cohort was derived. Having
a clear plan in place before data are collected or analyzed
is always recommended. It is also recommended that all
observational studies are registered with an established
registry (e.g., clinicaltrials.gov) a priori, despite not having
an intervention per se.
Selecting the study population and parameters
Clearly specifying and matching the study population to
the research question is critical, including having predefined
inclusion and exclusion criteria. These eligibility criteria
should relate to key factors appropriate to the bone and
nutrition research questions such as age, disease state, sex,
or physical activity (12). In observational research, groups
compared based on nutritional exposures should be as
similar as possible with regard to other important baseline
and/or demographic or geographic parameters to address
the primary objective of the study. It should be noted that
certain subpopulations are more prone to changes in bone
and require specific considerations in recruitment and anal-
ysis. Some examples include adolescents, perimenopausal
women, older adults, bariatric surgery patients, and those
with compromised kidney function. The large changes in
bone in these subgroups can mask more subtle effects of
the diet. Larger sample sizes are needed to assess differential
rates of bone accrual in puberty or bone loss as occurs
with menopause, or a more narrowly defined sample can be
selected to create a more homogenous group.
Nutritional exposures across the life course have the
potential to influence bone health. However, the risk of
osteoporosis and low trauma fragility fractures in adults
increases exponentially with age, especially among women
392 Bailey et al.
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(13). Thus, carefully matching the age of the participants
to the research question is critical. In addition, baseline or
underlying nutrition status of the cohort or sample is also
critical in any type of research study in the field of nutrition as
this may influence the magnitude of response or the strength
of any association (8). Similarly, UV exposure patterns differ
substantially based on geographic location and must be
considered. Provision of nutrients to an already adequate diet
is unlikely to produce measurable health benefit—we have
seen this with regard to a number of health outcomes but
information is limited for bone. One example comes from the
Women’s Health Initiative that studied the effect of calcium
and vitamin D supplementation on hip fracture. When
individuals who were using their own calcium and vitaminD
supplements (i.e., essentially receiving recommended intakes
of calciumand vitaminD)were included in the analysis, there
was no significant reduction in hip fracture (14). However, in
re-analysis of the same data with the exclusion of those taking
personal supplements and those who were noncompliant
with the study supplements, there was a significant reduction
(30%) in hip fracture among those randomly assigned to
receive the study supplements (15).
Selecting appropriately validated endpoints or surrogate
markers of disease risk or bone health also needs careful con-
sideration to ensure that a study is able to accurately answer
the question included (16). Endpoints should be quantitative
or adjudicated [e.g., bone mineral density (BMD) or frac-
ture], if possible, and biomarker measurements should be
compared to a reference standard, if available. Additionally,
nutritional biomarkers, such as serum 25-hydroxy-vitamin
D (25(OH)D), can also be used to measure nutritional
status. The National Institute of Standards and Technology
has reference methods and materials for use in research
studies for some nutritional biomarkers. Careful planning
of the frequency and types of nutrition assessments to be
made is recommended. This is especially true for 25(OH)D,
which is known to change appreciably with UV exposure;
so in some locations, seasonality should be considered
(17).
The effect size of any 1 nutritional exposure on bone
may be small, even in RCTs, but that is not to negate its
importance (18). Furthermore, in the context of nutrition
and bone, measurement error in dietary assessment tends
to attenuate nutrition and health relations, so null findings
may be observed even if a true relation exists. With changes
in bone, the intervention effect may be small but compared
to a control group that exhibits traditional bone loss,
the difference may be larger. For example, daily calcium
supplementation for 18 mo in French women was associated
with a small change in BMD (19), but a substantially lower
risk of bone fracture (19, 20). Also, small or short-term
changes can have a cumulative impact (21). Therefore, it is
necessary to examine the totality of the evidence, respecting
that even null and small effect sizes taken together are
important when considering the level or strength of the
evidence. Finally, nonpublication of null studies could lead
to publication bias.
Reducing confounding and bias
All studies are susceptible to different levels and types of
biases. The goal of the investigators is tominimize bias during
the development and execution of the study and to report
and consider bias while interpreting the study results. Bias
in evaluating the effects of diet on the risk of any disease may
relate to imperfect sampling, data collection and handling,
and statistical analysis and confounding effects of risk factors
that are correlated with the aspect of diet under study (22).
Choice of the right comparison groups can dictate the extent
of bias in a study; for example, in cohort studies, differential
loss to follow-up tends to be 1 of the main sources of bias
(23). A number of nutrition and bone studies tend to be
retrospective cohort studies, where selection of exposed and
unexposed groups should be done without knowing the
outcome. Strategies for reducing confounding and bias vary
depending on the study design. In observational research,
confounding can be reduced in the study design phase by
restricting the sample on an important dimension (such
as sex or age) or by matching of participants, or in the
analysis phase through use of stratification and adjustment
as discussed later in “Pertinent factors for consideration in
statistical analysis.” Failure to account for and document
all potentially confounding factors and assumptions limits
our ability to synthesize the research literature with meta-
analyses (24). This results in high variability and dampens
effect sizes for relations between diet and health.
Sample size estimation
Sample size is a vital aspect of any study and the statistical
power of a study should be estimated at the design phase.
The sample size not only dictates the cost of collecting
data, but also is critical to ensure that true or clinically
meaningful associations or effects can be detected (25, 26).
When reporting, sample size calculations should consider
the primary outcome, the test statistic, the null hypothesis
and the alternate hypothesis, the probability of erroneously
rejecting the null hypothesis (the type I error), and the
probability of erroneously failing to reject the null hypothesis
(the type II error) (12). For nutrition research, effect size
and expected variability of a nutrient (27), along with the
duration of the study to observe any effect of a given nutrition
intervention and any statistical interactions that will be tested
should also be considered.
Statistical analysis
Ideally, a researcher will decide on the statistical methods to
employ either before the data are collected or when designing
a research study of existing data (12). The analytical sample of
participants in the primary analyses should be documented
in any research dissemination efforts (12). Because all studies
are susceptible to bias, the goal of the investigators is to
minimize bias during the development and execution of the
study and to take bias into account while interpreting the
study results. Bias in evaluating the effects of diet on the risk
of any disease can stem from imperfect sampling, imperfect
Research guidelines for nutrition and bone 393
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information gathering, and the effects of risk factors that are
correlated with the aspect of diet under study (22).
Overview ofMethods to Assess Bone
This section provides a brief overview of the measures
currently available to estimate different parameters of bone
health and fracture risk. This information can be useful
to inform selection of appropriate outcomes in the design
of studies as well as to help researchers select outcome
measures for secondary analysis of previously collected data.
All measures of bone health or fracture risk outlined below
have strengths and limitations that need to be included
when interpreting dietary studies. The selection of the bone
outcome, and therefore, the measure to assess it are largely
driven by the research question, sample size, length of follow-
up, the skeletal sites of interest, the outcome of interest,
safety and risk considerations, and the availability and costs
associated with measurement.
Bone mass or density, turnover, structure, and strength
can be assessed (or estimated) with use of a number of
different methods including direct measurement of the bone
or through the use of surrogate endpoints or biomarkers.
Bone quality is an umbrella term often used to encompass
3 key facets of bone health: the composition of the bone, the
geometry of the bone, and the microarchitecture of the bone
(28); however, because bone is in a constant state of flux,
understanding the rate of turnover is also an important di-
mensionnot captured directly by bone quality.Developments
in imaging technology have allowed assessment of bone
properties in humans noninvasively. Different approaches
are required for each of these properties. The best approach
may vary according to the life-stage and methods available,
and may be more limited in children than in adults (29).
To date, only bone density or mass and bone geometry are
used extensively to evaluate changes in bone prospectively.
Bone fracture is an ideal outcome to study in observational
research rather than in clinical trials because of the large
sample sizes needed with this as the primary outcome.
However, skeletal and nonskeletal factors are associated
with fractures, so careful consideration is needed when
interpreting nutritional exposures. A comparison ofmethods
for assessing bone mass, BMD, bone strength, and bone
turnover is outlined inTable 1. If possible, it is recommended
that different methods of assessment are examined because
of limitations in measurement, and comparing different
methods with multiple bone sites may yield similar or
dissimilar results (30).
Measurements of bone composition, microarchitecture,
and geometry
DXA is the most common bone densitometry tool used to
assess bone (and body composition) that relies on the use
of 2 X-ray beams of different energy to determine the bone
mineral content (BMC, in g) and areal BMD (aBMD, in
g/cm2). Most prospective studies since the late 1980s have
used DXA to measure these skeletal traits at the whole
body level or at specific sites such as the lumbar spine,
proximal femur, and radius. The strengths of this technique
are the short scan times, low radiation dose, and wide
availability. However, a key limitation is that it only provides a
2-dimensional assessment of bone and accounts for only 60–
70% of variation in bone strength (31, 32).
Currently DXA represents the gold standard for the
diagnosis and monitoring of osteoporosis in adults because
it is linearly related to fracture risk (32). For diagnosis of
osteoporosis, WHO recommends that aBMD be expressed
in terms of SD and compared to a reference range derived
from a population of young healthy adults (33). Specifically,
osteoporosis is defined as an aBMD value>−2.5 SDs below
the young adult reference group, whereas low bone mass
(osteopenia) is defined as an aBMD value between−1.0 and
−2.5 SDs below the young adult reference group mean.
DXA is a complicated measure in obese individuals
because of weight limitations and scan area restrictions (i.e.,
width of bed for a total body scan). Some reports suggest that
DXABMDmeasurements are falsely elevatedwith increasing
body fat, which leads to an overestimation of BMD in obese
individuals. Other reports have shown that the precision
of DXA BMD declines with increasing BMI (20, 34), and
suggest that serial measurements in obese subjects should be
treated with caution and may require a longer time interval
between scans to detect changes in BMD because of the
higher least significant change. One of the recommendations
from the International Society for Clinical Densitometry
(ISCD) is to perform a forearm BMD scan for very obese
patients who are over the weight limit of the DXA tables.
Bone strength is only partly described by DXA. A hip
structural analysis algorithm can be used in adults together
with BMD to estimate structural strength from subperiosteal
width, cross-sectional area, and section modulus in the
proximal femur (35, 36). The hip axis length (HAL) is
a measure of the distance from the base of the greater
trochanter to the inner pelvic rim (37). The ISCD released
a position paper on measures of hip geometry in 2015,
including specific recomendations on hip structural analysis
and HAL; currently, HAL is the only endorsed measure to
assess hip fracture risk in women (38).
In children, BMC is preferred over BMD as the DXA
measure to evaluate/report, together with weight and height,
to capture the changes with growth over time (39, 40). In
a study of 6,213 children at mean age of 9.9 y followed
prospectively for 2 y, total body (less head) aBMD showed a
weak inverse relation with subsequent fracture risk (OR per
SD decrease of 1.12; 95% CI: 1.02, 1.25), but BMC, adjusted
for bone area, height, and weight, showed a stronger relation
(OR 1.89; 95% CI: 1.18, 3.04) (41). An important application
of prospective DXA measures through the pubertal growth
spurt is the determination of timing and magnitude of
BMC gains as well as sex differences (42–44). The National
Osteoporosis Foundation position paper on development of
peak bone mass discusses various ways to adjust BMC to
account for size in children (1).
MRI provides a volumetricmeasure of bone geometry and
bonemicroarchitecturewithout radiation exposure. It has the
394 Bailey et al.
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TABLE 1 Comparison of methods for determining density or mass, strength, and turnover in humans1
Outcomes DXA pQCT HRpQCT MRI QUS
Dynamic histo-
morphometry
Biochemical
markers of bone
turnover
BMC or BMD Yes Yes Yes No No Yes No
Bone balance Weak No No No No No No
Bone turnover
rates
No No No No No Bone formation
rate
Yes
Speciﬁcity 
aBMD/BMC/bone Ca
content, whole body
and individual sites

vBMD, individual
sites trabecular
and cortical

trabecular
and cortical

trabecular
and cortical
  
Ability to detect
short-term
changes
      
Safety       
Cost       
Availability of
method
      
Overall
assessment
FDA approved but
large sample size
required
Get measure of
bone strength
Measures
microarchi-
tecture
Not well
developed
Less understood Invasive Bone formation
and bone
resorption can
be determined
separately but
higher variability
1More checks indicates higher impact. aBMD, areal bone mineral density; BMC, bone mineral contents; BMD, bone mineral density; DXA, dual-energy X-ray absorptiometry;
HRpQCT, high resolution peripheral quantitative computed tomography; MRI, magnetic resonance imaging; pQCT, peripheral quantitative computed tomography; QUS,
quantitative ultrasonometry; vBMD, volumetric bone mineral density.
advantage of being able to measure the axial or peripheral
skeleton, but does not provide a measure of BMC or BMD.
While application of the method is still in development (29),
given the high cost and limited availability and the fact that
assessment of MRI scans is technically challenging, it is not
ideal for use in observational research with large sample
sizes. More research is needed to determine whether use of
MRI scans will offer more information about the effects of
nutrition on fracture risk beyond DXA.
Quantitative ultrasonometry (QUS) is measured on an
inexpensive, portable device, is easy to use, involves no
radiation, and thus may be particularly suitable for use in
children or in settings where DXA is not available (29). QUS
operates through transmission of sound waves through the
bone to quantify the speed and/or the degree of attenuation
of the sound wave (i.e., broadband ultrasonic attenuation)
(45). Calcaneal QUS is the only site that is endorsed by
the ISCD for QUS use because other sites have not been
extensively or rigorously studied for use. However, there
is much uncertainty about what the variables reflect, thus
limiting its use (29), particularly its use to assess relations
between diet and bone. Although it has been suggested
as useful for screening for osteoporosis (45); at this time,
QUS is not recommended as a single measure for assessing
nutritional influences.
Peripheral quantitative computed tomography (pQCT)
came into use later than DXA to more directly measure
3-dimensional or volumetric BMD (vBMD) and geometry
of bone at appendicular skeletal sites, with minimal to
low doses of radiation (46). Importantly, this technique
allows trabecular and cortical bone vBMD to be measured
separately and can provide an assessment of total and cortical
bone area, cortical thickness, and estimates of bone strength.
Measures are taken at the distal and/or mid-shaft of the tibia
or forearm. However, relatively few studies have used this
technique to quantify the association between nutrition and
the various bone traits. A limitation of this technique is that
it typically provides a single slice at each of the skeletal sites,
which may not reflect skeletal changes at all bone regions.
The use of pQCT to assess fracture risk is less preferred
than DXA (47). pQCT has the advantage of being able to
assess vBMD and bone geometry at the clinically relevant hip
and spine sites. Using more advanced imaging software, it is
also possible to reconstruct the 3-dimensional image/shape
of bone and performed finite element analysis to stimulate
the mechanical behavior of bone. However, because of the
relatively high radiation dose it is not routinely used and not
appropriate for use in children (47). Although this tool has
been used to assess response to pharmacological treatments,
much less is known with regard to nutrition (46).
High resolution pQCT is a newer instrument (available
since the mid-2000s) that assesses microarchitecture and
vBMD in cortical and trabecular bone of the distal radius
and distal tibia. These instruments are becoming more
widely available, and offer the opportunity to evaluate bone
mechanical competence (48). The resolution is sufficient to
build finite element models of whole bone failure load, a
direct measure of fracture resistance (49). Cortical porosity
of trabecular plate and rod microstructure can also be
measured. This superior resolution has allowed character-
ization of sex differences in bone microarchitecture and
vBMD (46).
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Measurements of bone turnover markers
A number of biomarkers exist to measure bone turnover
in the blood and urine; thus providing a noninvasive and
relatively cost-effective tool. Bone turnover markers (BTMs)
are an attractive tool because they allow determination of
changes in bone formation rates versus bone resorption
rates and may help to identify patients at high risk of
fracture and to monitor the efficacy of medications or other
treatments, such as nutritional therapy or modifications.
Moreover, changes in bone are assessed in real time and
therefore provide a shorter period than a serial collection of
BMD or BMC.
A complete review of the utility and function of BTMs
is published elsewhere (50, 51). Briefly, BTMs are divided
into those that measure bone resorption and those that
measure bone formation. Osteocalcin, a noncollagenous
protein abundant in bone matrix, measures both dimensions
of the bone remodeling cycle and can be used as an overall
indicator of bone turnover because it is secreted during bone
formation, and can be monitored in fasting serum or urine.
However, osteocalcin has other actions not specific to bone
formation including bone resorption, described below (16).
Ideally, having a combination of both types of measures gives
a better overall picture of turnover rates and choosing only
1 BTM in isolation is limited in interpretability.
BTMs are subject to large variability, so their use requires
large sample sizes and does not give quantitative measures
of changes in bone, thus limiting their fit for purpose,
especially for monitoring (52). Many BTMs are specific
to bone collagen, not changes in mineralization. Overall,
BTMs have varying analytical and predictive quality and
have some limitations (see Table 1) (16). As with any
analytical specimen, protocols for collection and storage of
BTMs are recommended. Shetty et al. (53) recommend that
BTM samples be collected after an overnight fast, and that
subsequent serial measurements be done at the same time of
day and during the same season to reduce random variation
as much as possible.
Markers of bone formation.
These biomarkers reflect the activity of the osteoblast, the
bone building cells that support the formation of the bone
or procollagen metabolism (51). Because type I collagen
represents 90% of the organic bone matrix, measurement
of its peptides has been employed to assess bone formation
primarily through procollagen 1 N-terminal propeptide
(P1NP), but to a lesser extent procollagen 1 C-terminal
propeptide (P1CP). P1NP and P1CP concentrations in the
serum are highly specific for bone formation (i.e., type
I collagen is synthesized in other tissues like skin), and
most serum P1NP originates from bone, but is influenced
substantially by the assay technique used and by med-
ications (e.g., glucocorticosteroids and bisphosphonates).
P1NP is considered the most precise of the bone formation
markers and is recommended as a reference marker for
the prediction of osteoporosis risk and treatment-induced
changes by the International Osteoporosis Foundation and
International Federation of Clinical Chemistry (16). Bone
alkaline phosphatase is another widely used bone formation
marker and has been identified as an independent risk factor
for osteoporosis (54).
Markers of bone resorption.
These biomarkers reflect the activity of the osteoclast, or
provide a marker for collagen degradation. BTMs for bone
resorption are more variable than those for formation.
Most bone resorption markers are degradation products
of type I collagen; pyridinoline and deoxypyridinoline are
released during bone resorption and excreted in urine in
a free form and in a peptide-bound form, which are C-
terminal crosslinking telopeptides (CTX) and N-terminal
crosslinking telopeptides. CTX is the most precise bone
resorptionmarker (55) and is recommended by International
Osteoporosis Foundation and International Federation of
Clinical Chemistry (16). Both serum and urine CTX are
fairly specific to bone, but influenced by many sources,
including renal function as CTX is degraded in kidney
(56). Tartrate-resistant acid phosphatase (TRAP) 5b, which
reflects a noncollagenous protein, has also been used as a
resorption marker.
Various bone turnover markers have been used in the
observational literature of nutrition and bone health, usually
in combination of some bone formation and resorption
markers (57–62). For example, in a cohort of perimenopausal
Scottish women, higher dietary anthocyanidin intake was
associated with lower markers of bone resorption markers
(pyridinoline and deoxypyridinoline) as well as higher BMD
(59).
Assessment of fracture risk
Bone fracture can result from skeletal and nonskeletal
causes; this is an important distinction in understanding
how nutrition can influence fracture risk. Fractures have
been self-reported, confirmed by a medical professional or a
medical record, or self-reported and then adjudicated. The
latter 2 offer the best classification of risk. Incident bone
fracture is a complicated endpoint. Fracture ascertainment
has also been assessed using bone fracture registries. Previous
studies have demonstrated the utility of fracture registries
to successfully examine the relation between nutrient intake
and bone fracture outcomes (63). However, the association
of a nutrient with fracture risk and incidence can vary by
site (e.g., in 1 study protein was associated with decreased
hip fracture, but not spine fracture) (34); thus, multiple sites
should be examined as differential effects of nutrients can be
exhibited by type of bone and skeletal site.
Fracture risk assessment tool (FRAX) is a country-specific
algorithm that integrates important clinical risk factors for
fracture and mortality risk, with or without information on
BMD to compute the 10-y probability of hip fracture ormajor
osteoporotic fracture (64). It was developed with the WHO
Collaborating Centre for Metabolic and Bone Diseases at
Sheffield, UK, and to date is the most widely used tool to
generate fracture probabilities (65). FRAX is not useful for
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monitoring effectiveness of treatments and is limited to hip
BMD and therefore does not reflect the spine. Reference data
may not reflect certain populations and are limited to the
ends of the age range.
Pertinent Factors for Consideration in Dietary
Assessment
Nutrition is an important and modifiable factor with regard
tomany diseases of public health concern (66).However, how
a researcher operationalizes “nutrition” is key to examining
relations with bone as well as to select the appropriate
bone health biomarker or outcome. Nutritional status can
be assessed by reported or observed dietary intakes and
practices, biomarkers of nutritional status, anthropometry
measures, clinical observation, and functional testing. Diet
can be further broken down into nutrient or bioactive intake,
dietary patterns, or intakes of selected food groups. How diet
and/or nutritional status is operationalized should be clearly
defined when designing and analyzing data.
Dietary assessment methods
Multiple methods exist for assessing dietary intake and
are reviewed elsewhere in great detail (67). Briefly, several
methods exist to collect dietary intakes including methods
for short-recall periods ranging from a day to several weeks
(24-h diet recalls, diet records, and diet diaries) andmethods
to estimate usual diet over an extended period of time,
such as FFQ and screening tools. No method is perfect
and assessment of self-reported diet has several limitations,
including recall bias and measurement error.
Food records and diaries.
A food diary or record is a summary of all foods and bever-
ages consumedwithin a specified period of time. Accuracy of
records is enhanced when participants/people are trained to
weigh or measure the foods and beverages being consumed.
In general, recording multiple nonconsecutive days of intake
puts large burden on a participant and correlated days of
intakes can occur (68). Food diaries are subject to reactivity,
that is, when a person changes their intake because they are
recording it.
24-h dietary recalls.
A24-h recall is amean to assess an individual’s intake over the
previous 24 h and can be assessed in person, over the phone,
or through web-based platforms and mobile applications.
Multiple 24-h recalls are recommended based on day-to-
day variability in intake. Day of the week, season, mode of
interview (telephone or in-person), and the sequence of the
24-h recall are known to influence reported energy intakes.
Reported intake of macronutrients from 24-h recalls, which
are consumed in large amounts every day, is generally more
stable than those for micronutrients (69). The use of probing
questions aids the ease of responses and has been shown to
enhance data accuracy (70).
Frequency-based methods.
An FFQ is a longer-term instrument and is often used
in large cohort or case-control studies. FFQs assess di-
etary intake over a specified period of time and query
how often a person consumed multiple food items that
are aggregated into groups with similar nutrient profiles.
FFQs can be quantitative, semiquantitative, or qualitative
(71). FFQs offer a more cost-effective alternative to the
24-h recall; however, they limit the scope of foods that can
be queried. The FFQ may create participant burden, and
may be difficult or confusing to complete. Most importantly,
the accuracy of nutrient profiles determined by FFQs has
been questioned. The 24-h recall has been shown to be a less
biased estimator of energy and protein from foods in adults
than a frequency-based instrument (72), but little is known
about other nutrients for which recovery biomarkers (reflect
dietary intake in a specific time period and, therefore, can be
used to estimate absolute intakes) do not exist.
Screening tools.
Various dietary screeners are available to rapidly assess
different dimensions of the diet such as nutrient intakes (73,
74), food group intakes (75), dietary patterns (76), nutrition
risk (77), food-related behaviors (67), and for identifying
malnutrition (78, 79). Short screening tools may be advan-
tageous when focusing on narrow research questions. For
example, Yang et al. (74) developed a calcium screening
tool that was validated against BMC in adolescent girls;
such tools provide bone researchers opportunities to leverage
comprehensive assessment of bone and combine it with rapid
and reliable measurement of nutritional exposures.
Measuring dietary supplement use.
Given that dietary supplement use can be pervasive (80–
82), knowledge of nutrients and bioactives are critical to
determine nutritional status. In adults, but not in children,
those who use dietary supplements tend to have significantly
higher intakes of vitamins and minerals from food sources
alone, so it is always important to include assessment of
dietary supplements (83). Dietary data without the inclu-
sion of dietary supplements overestimate the prevalence of
inadequacy and underestimate the prevalence of potentially
excessive intakes (83–85).
Selection of methods
Many factors should be considered when choosing the
method to assess or characterize dietary exposures. The
National Cancer Institute Dietary Assessment Primer is
a valuable resource to guide researchers in making such
decisions; Table 2 comes from the Primer and compares the
common dietary assessment methods (67). An important
issue with nutrition studies is to assess and characterize
“baseline” or underlying nutrition status that can greatly
influence the relations observed between diet and bone.
Utilizing biomarkers in addition to self-reported diet is
recommended, when available and appropriately validated,
including recovery biomarkers, predictive biomarkers, and
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TABLE 2 Comparing dietary assessment instruments1
24-h recall Food record FFQ Screener
Study design Cross-sectional    
Retrospective — —  
Prospective    
Intervention  —  
Scope of interest Total diet    —
One or a few components — —  
Captures contextual details regarding
food preparation, timing of meals,
location of meals, etc.
Yes   — —
No — —  
Time frame of interest Short term   — —
Long term — —  
Can be used to query diet in distant past Yes — —  
No   — —
Allows cross-cultural comparisons Yes   — —
No — —  
Major type of measurement error Random   — —
Systematic — —  
Potential for reactivity High —  — —
Low  —  
Time required to complete <15 min — — — 
>20 min    —
Memory requirements Speciﬁc  — — —
Generic — —  
Does not rely on memory —  — —
Cognitive diﬃculty High — —  
Low   — —
1Reproduced from the NCI Diet Assessment Primer (67).
concentration biomarkers (see “Biomarkers of nutrition
status”). More details on how regression calibration can be
used to combine dietary and biomarker information for
predicting health outcomes are given by Freedman et al.
(86); but, as yet, this has not been applied to the context of
nutrition and bone.
Participant characteristics.
Energy and nutrient consumption and dietary supplement
use varies with age, sex, and race/ethnicity, particularly for
bone outcomes. Therefore, valid nutrition assessment tools
should be selected based on the population group assessed
(87, 88). Valid dietary questionnaires should detail foods
typically consumed by the population of interest, including
appropriate portion size and preparation, and should use an
adequate food composition database for nutrient calculation
(88). Regarding FFQs, several culturally appropriate FFQs
have been developed and validated for use in different
populations around the world (89, 90). For example, among
Puerto Rican adults, the use of a general FFQ for the US
population significantly underestimated energy and nutrient
intake relative to a 24-h dietary recall. Regarding food
preparation, the FFQ excluded cooking oil in rice, a highly
consumed food in this population, thus underestimating
both energy and fat intake (89). Population-specific dietary
assessment tools should be considered to aid researchers
looking at bone.
Time/duration of study.
For some research questions, usual intakes may be more
informative but other questionsmay require amore temporal
assessment. For bone, dietary exposures may need to be
examined as a cumulative function, rather than a snapshot
(91). For cohort studies, measurement of current diet and
repeated assessments over the follow-up period are necessary
to evaluate diet at baseline and changes over time. The use
of repeated measurements of dietary intake provides analytic
opportunities to reduce the effect of measurement error and
to evaluate a variety of temporal relations between diet and
disease (i.e., long latency, short latency, cumulative exposure)
(88). In cohorts followed for longer duration,multiple dietary
measures must be collected frequently because the diet may
change over time.
Nutrients, foods, and dietary patterns.
Researchers may be interested in specific nutrients, groups
of nutrients (i.e., calcium and vitamin or B vitamins), foods,
food groups, or eating/dietary patterns in relation to bone (2,
3, 91, 92). However, the National Osteoporosis Foundation
position paper on development of peak bonemass concluded
in a series of systematic reviews that only the evidence for
calcium intake and development of peak bone mass was
grade A evidence given the lack of available data on the other
nutritional factors examined (1).
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Foods can be categorized into similar groups on the
basis of their content of nutrients and other bioactives.
Food groupings also serve as the basis for deriving dietary
patterns and evaluating how diets conform to reference
standards for intakes such as the Dietary Guidelines. Dietary
patterns are defined as “the quantities, proportions, variety or
combination of different foods, drinks, and nutrients in diet,
and the frequency with which they are habitually consumed”
(93). The dietary pattern approach has advanced nutrition
research by capturing overall food consumption behaviors
and its quality in relation to health and may better predict
disease risk and provide more meaningful food-based public
health recommendations (94), anddietary patterns have been
successfully applied to study bone outcomes (95).
Limitations with dietary assessment
All dietary assessment methods are subject to error (72, 96,
97). It is now recognized that the error in self-reported di-
etary assessment instruments must be considered in analysis
and interpretation of findings because measurement error
in dietary assessment can lead to spurious associations (98).
Underreporting has long been demonstrated in nutrition
research and in diverse populations to be associated with
age, BMI, and education among other factors (99, 100).
Other work suggests that 24-h recalls are much less biased
for energy intakes and intakes of protein, sodium, and
potassium than FFQs (96). Although measurement error
is unavoidable in any biologic or physical measurement, it
is important to estimate the magnitude of the error and
if the effect of measurement error is substantial, statistical
corrections should be considered (88). Furthermore, all
dietary data, including dietary supplements, are also limited
by the accuracy and currency of the databases that are
employed to estimate intakes. Therefore, it is important to
have a standardized survey protocol and dietary assessment
method based on the past research experience of diverse
researchers carefully matching the method to the study
population. Furthermore, to calculate highly reliable nutrient
intake from dietary assessment methods, it is important
to secure a researcher with sufficient expertise in using
databases to convert foods and beverages as reported by study
participants to the component nutrients, food groups, and/or
dietary patterns of interest.
Biomarkers of nutrition status
Nutritional biomarkers are reliable and accurate biochemical
or other measurements that can be objectively measured
and evaluated and used as indicators of dietary intake,
biological processes, nutritional status, pathological pro-
cesses, pharmacological responses to an intervention, or
health outcomes (101, 102). The National Institute of Health
defines biomarkers as any biological measurements that
indicate “normal biological processes, pathogenic processes,
or pharmacologic responses to therapeutic intervention”
(101). There are a wide range of biomarkers available for use,
but their utility depends on the purpose (103).
Nutritional biomarkers are biochemical, functional, or
clinical indices of nutrient intake, status, or their functional
effects that can reveal information about biological or
physiological responses to dietary behavior or pathological
processes, as well as monitor responses to therapeutic
interventions and provide information on inter-individual
differences in response to diet and nutrition (104). Nu-
tritional biomarkers can be obtained from blood, urine,
bone, saliva, skin, adipose tissue, and finger- and toenails.
Nutritional biomarkers are loosely broken down into those
that reflect nutritional exposures (i.e., intake), nutritional
status, and those that can be used to predict health outcomes,
often referred to as surrogate endpoints (105).
A complete review article of the available nutritional
biomarkers with their fit for purpose and limitations can be
found elsewhere (106). Recovery biomarkers reflect dietary
intake in a specific time period and, therefore, can be used
to estimate absolute intakes (e.g., energy intake estimated by
doubly labeled water technique). Concentration biomarkers
refer to those that are correlated with dietary intakes and
can be used to estimate the ranking of an individual’s intakes
[e.g., 25(OH)D] (107). Urinary sucrose plus fructose reflects
dietary sucrose intakes with unusually high correlations,
but is labeled as a predictive biomarker because only a
small proportion of sucrose intake is recovered in urine.
Biochemical markers of bone turnover and BMD are the
most commonly used biomarkers of fracture risk as discussed
earlier. Some biomarkers, such as folate, are represented
by dietary intakes (108), whereas estimates of vitamin D
from the diet differ from serum 25(OH) D (109, 110). A
newer, rapid, but elaborate method for precisely evaluating
bone calcium retention makes use of the long-lived isotope
41Ca to label bone and follow the appearance into the urine
to quantitate whole body net bone loss in response to an
intervention (111). Use of natural stable calcium isotope
ratios has potential as a future biomarker of bone turnover
(112).
To be of utility in research, nutritional biomarkers
must be analytically valid. There are many biological and
methodologic issues that must be considered (105) and
not all nutrients have a biomarker to estimate status or
intake. For some nutritional biomarkers, factors such as
hydration status, inflammation, and diurnal variation all
influence measurements. Furthermore, the cost can be high
for assessing nutrition status through biomarkers, which is
often why dietary data are used. The use of cutpoints to
determine nutritional status is difficult (113).
Pertinent Factors for Consideration in
Statistical Analysis
Before formal analyses, data exploration and visualization
techniques should be used to calculate descriptive statistics
and generate plots using means and SD for continuous mea-
sures, with medians and interquartile ranges for measures
that deviate from a normal distribution (27). Any outlier
value should be further explored and appropriate approaches
can be used to limit the effect of outliers on the data.
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These approaches include i) keep the outlier and treat it
like any other data point; or ii) winsorize it (i.e., assign
it lesser weight or modify its value so it is closer to the
other sample values); or iii) eliminate it (114). To fulfill
the model assumptions, data can usually be transformed
to a more normal distribution with the use of the natural
logarithm or other appropriate transformation. However,
such transformation can result in challenges related to data
interpretation.
Data exploration and examination of the scale of a
nutrient will further shed light on the question of examining
a nutrient on a continuous scale versus in categories and
utilization of parametric methods versus nonparametric
methods. These 2 types of analyses can yield different
relations. The most powerful treatment of a variable is
to retain a continuous scale of measurement; however,
outliers and multimodal distributions can create problems
and exert undue influence. However, categorization is com-
mon using arbitrarily defined quantiles, standard round-
numbered cutpoints or points determined a priori such as
the DRI; similar issues exist with the use of cutpoints for
nutritional biomarkers (113). The primary analysis should be
based on cutpoints determined a priori, whereas secondary
analysis may use alternative cutpoints that best describe the
biological relation, or finer divisions of extreme categories to
extend the examination of the dose-response relation (88).
Categorical measures should be described using frequencies
and percentages.
Missing data are unavoidable in research studies for
various reasons and can dramatically shrink the sample size.
As a result, the precision of confidence intervals is harmed,
statistical power weakens and the parameter estimates may
be biased (115).Missing data can therefore lead to substantial
bias; however, this issue is often inadequately handled in
statistical analyses (116). During study execution, attempts
should be made to determine the full set of exposure and
outcome values for each subject at each examination. At the
analytic phase, several approaches can be used to account
for missing data, including maximum likelihood methods
and the multiple imputation methods described by Little
and Rubin (117). Overall, authors should explicitly state
the assumptions underlying the handling of the missing
outcomes and justify them through data descriptions and
sensitivity analyses (116).
Consideration of covariates and confounders
While analyzing a single nutrient it is key to adjust for
important or clinically relevant confounders or covariates
related to bone measures such as age, sex, weight, height,
current smoking, physical activity, menopausal status and
current estrogen replacement (in women alone) (118). In
addition to these covariates, careful consideration should be
given to dietary confounders, such as intakes of total energy,
calcium, vitamin D (including from UV exposures), alcohol,
and caffeine intake (3, 119, 120). Furthermore, substitution
analyses can be used to answer the research questions related
to the effect of substituting a specified percentage of energy
from 1 nutrient (e.g., protein) for the same percentage of
energy from another nutrient (e.g., carbohydrates) (107).
While analyzing type of nutrients, nutrient types should be
adjusted for each other, provided there is no collinearity
between nutrient types. For example, animal and plant
protein should be adjusted for each other in the same
model when analyzing the association of protein type with
bone measure (121). Imperfectly measured or unmeasured
confounders cannot be ruled out in observational studies
and this can result in residual confounding. Directed acyclic
graphs (122) and change-in-estimate procedures (123) can be
used for confounder identification and selection during data
analysis.
Addressing interactions in nutrition studies
Nutrition analyses are often complex because of issues
related to interactions between nutrients. For example, in
the context of nutrition and osteoporosis studies, interaction
is commonly reported between dietary protein and calcium
intakes. Investigators should review the nutrition literature
to plan the analyses related to interactions a priori. Similarly,
in osteoporosis research, sex is an important effect modifier
and analyses are often conducted stratified by sex and some-
times by age (young compared with old). Any significant
interactions should be further analyzed in stratified analyses,
which could be key to isolating the individual effect of
a nutrient. Most statistical procedures have an underlying
assumption that the data are independent (12), which may
or may not be the case in nutrition and bone. There is often
collinearity of both foods and nutrients. Similarly, BMC from
1 skeletal site is likely to be related to BMC of another site
or total body BMC. Therefore, before formal analyses, data
exploration techniques should be used to assess correlations
and collinearity between nutrients of interest. Appropriate
modeling strategies should be used if 2 nutrients are collinear.
Issue of multiple comparison
In nutrition and bone studies, there are often many variables
under consideration, with the potential for a large number of
statistical comparisons to be performed. While the issue of P
value adjustment for multiple comparisons in observational
epidemiology has been a source of discussion for years
among epidemiologists (124), it is generally accepted that
the P value is not the sole criterion for assessing relations
in observational studies (e.g., 95% CI are an informative ap-
proach to presenting the data) (125). Therefore, conclusions
should be based on the preponderance of scientific evidence
related to the hypothesis, considering the point estimates
and confidence intervals rather than a single statistical result.
However, emerging research is utilizing genomic, proteomic,
and metabolomic approaches as endpoints in nutrition
studies. Such studies often have multiple endpoints and no
prior hypotheses, which raises statistical issues (126). In such
studies establishing a threshold for statistical significance
(i.e., a P value) to address multiple comparisons becomes
even more important (124).
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Special Considerations for Nutrition and Bone
Relations
In addition to various nonmodifiable factors (e.g., genetics,
sex, maturation), a range of modifiable lifestyle and phys-
iological factors are known to influence bone, including
physical activity, sedentary behaviors, bodyweight or obesity,
muscle mass and strength, as well as certain medications
(Table 3). Given that various nutritional factors can influence
or interact with some of these factors and directly or
indirectly impact on bone, it is important to consider and
plan analyses for any potential interactions with these factors
a priori.
Body weight
Excessive body weight (i.e., overweight and obesity) and
higher BMI has been linked to an increased bone density,
which has been attributed largely to the additional strain
placed on bone from increased load (1, 2, 127, 128). In
terms of fracture risk, there are mixed findings regarding
the association with BMI or the level of obesity. A meta-
analysis of prospective studies (6 studies with 105,129
adults) reported no overall relation between BMI and the
risk of vertebral fracture; however, when stratified by sex,
there was a significant inverse association between BMI
and fracture risk only in men (129). Interestingly, BMI
was associated with an increase in fracture risk in women
when models controlled for BMD (129). In part support of
these findings, a meta-analysis of prospective cohorts from
more than 25 countries (398,610 women, average age 63 y)
reported that a high BMI (35 kg/m2) was associated with
a reduced risk of osteoporotic fracture, but when adjusting
for BMD the risk of fracture was increased (130). However,
adding to the complexity, this study also showed that the
association betweenBMI and fracture risk differed by skeletal
sites.
Previous research has also demonstrated that caloric
restriction andweight loss are associatedwith increased bone
loss (131, 132), but this can be counteracted by the inclusion
of exercise in a weight loss program (133, 134). Although
the mechanism(s) for bone loss during weight loss is likely
to be multifactorial, reduced mechanical loading associated
with weight loss is likely to be an important contributor.
However, it is also important to acknowledge that the relation
between weight (fat) and bone is influenced by a number
of hormonal and inflammatory cytokines or adipokines
(cytokines secreted by adipose tissue). For instance, adipose
tissue acts as an active endocrine organ that can secrete a large
number of proinflammatory adipokines as well as attenuate
the release of anti-inflammatory markers (e.g., adiponectin),
all of which have been implicated in bone and muscle loss,
osteoporosis, and an increased risk of fracture. Although
further research is needed, it is important that weight or BMI
(or the degree of change in weight) be included in anymodels
when assessing the association between nutrition and bone
or fracture risk.
Muscle (sarcopenia)
Muscle and bone are inextricably linked by a shared loading
environment (and common genes regulating body size)
(135). This biomechanical link between muscle and bone is
supported by the concept of the functionalmuscle-bone unit,
which predicts that changes in muscle mass, size, or strength
should influence themass, structure, and/or strength of bone
predictably and correspondingly (136). Indeed, previous
research has reported that both muscle mass and strength
(and changes in these measures) are associated with BMD
(and bone gains or losses) in both children and older adults
(137–140). More recently, there has been interest in the inter-
relation between sarcopenia, which is defined as low muscle
mass, strength, and/or impaired function, with osteoporosis
and fractures (141). In 2009, the term “sarco-osteopenia” was
coined to emphasize that low BMD or osteoporosis and weak
muscles may contribute to fractures in elderly adults (142);
data suggest that those with low BMD and sarcopenia are
at a higher risk of fracture than those with low BMD or
sarcopenia alone (143). Because poor nutrition is a risk factor
for both these conditions (144), it is important to consider
indices ofmuscle or sarcopenia in the studies of nutrition and
bone health.
Physical activity and sedentary time
There is consistent and compelling evidence that physical
activity or exercise training, particularly weightbearing im-
pact sports or activities and muscle-strengthening exercises,
can improve peak bone mass during growth and maintain
or slow bone loss throughout life (145–147). Central to
understanding how bones adapt to exercise (loading) is
Frost’s mechanostat theory, which postulates that loads
(strains) imparted on bone must exceed a given threshold or
setpoint to turn on bone modeling or remodeling to elicit an
osteogenic response. Conversely, when strains on bone are
reduced such as during disuse or bedrest, there is rapid bone
loss. As a result, not all forms of physical activity or exercise
training have a positive effect on bone; regular walking,
swimming, and cycling have been shown to have little or no
effect on bone. Recent research has also shown that prolonged
periods of sedentary behavior during daily life, such as sit-
ting, are associatedwith lowBMDand sarcopenia (148–150).
It is therefore important that all nutrition and bone studies
include physical activity or exercise as a confounding factor
and/or test for any potential exercise-nutrition interaction.
For instance, there are some reports that additional calcium
may enhance the effects of exercise on bone in children
and older adults, particularly those in a state of nutritional
calcium insufficiency (151–153). Others have reported that
the provision of additional protein can lead to greater
resistance training–induced gains in muscle mass and/or
strength compared to resistance training alone in older adults
(154), particularly in those with inadequate basal protein
intakes or those who are institutionalized or sarcopenic
(155, 156).
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TABLE 3 Potential confounders to the relation between nutrition and bone, and their methods of assessment and strengths and
limitations1
Method of assessment
Direct measure Self-report Advantages Limitations
Anthropometry
Weight and height    Simple, quick and noninvasive  If self-reported, errors in
underreporting weight and
overestimating height
BMI — —  Simple, inexpensive and noninvasive  Does not distinguish fat and lean mass
Body composition
DXA  —  Easy to use
 Short scan time
 Low radiation
 Good precision
 Assess total body and regional fat and
lean mass
 Expensive
 Not suitable for very obese individuals
CT (including peripheral
CT)
 —  High accuracy and reproducibility
 Excellent soft tissue diﬀerentiation
 Expensive
 Limited access
 High radiation exposure (CT)
 pQCT has lower radiation dose but is
limited to appendicular sites
MRI  —  High accuracy and reproducibility
 Excellent soft tissue diﬀerentiation
 No radiation
 Expensive
 Limited access
 Claustrophobia
Bioelectrical impedance  —  Simple, quick, noninvasive, and
portable
 Accurate measurements
 Can be aﬀected by hydration status
Physical activity/sedentary time
Recalls and questionnaires    Simple and easy to administer
 Able to measure a large number of
participants at low cost
 A variety of physical activities can be
assessed
 Able to compare results from diﬀerent
locations when using the same
questionnaire
 Issues related to reliability and validity
 Recall challenges from some
populations
May lack sensitivity for detecting
modest changes
Pedometers  —  Small, lightweight, noninvasive, and
inexpensive
 Easy to administer to large groups
 Objective measure of most common
activity (walking)
 Does not measure frequency,
intensity, or duration of activity
 Cannot be worn during aquatic events
 No diﬀerentiation of activity type
Accelerometers/
inclinometers
 —  Small, lightweight, and noninvasive
 Low participant burden
 Real-time monitoring
 Provide information on sedentary
time and intensity, frequency and
duration of activity (inclinometers can
also distinguish sitting and standing)
 Expensive
 Cannot be worn during aquatic events
 No diﬀerentiation of activity type
 Underestimates activity during certain
activities (e.g., cycling and upper body
activities)
1CT, computed tomography; pQCT, peripheral quantitative computed tomography.
One of the challenges when examining the association
between bone and physical activity or exercise is that it
is difficult to quantify activity characteristics which are
relevant to musculoskeletal responses. Physical activity is
a multidimensional behavior and factors such as the type,
frequency, intensity, and duration need to be considered
given that not all forms of activity have a beneficial
effect on bone. For example, the Timed Up and Go test
performance and speed of walking is related to BMD and
risk of nonvertebral fracture (157), as measures such as grip
strength (158) have been associated with BMD and risk of
osteoporosis (159). Traditional measures of intensity that
focus on cardiovascular load, such as heart rate or estimates
of total energy expenditure, are not particularly useful in
studies with bone outcomes because they fail to capture key
bone-loading characteristics (e.g., type, magnitude, or rate of
loading) known to elicit an osteogenic response (see Table 3).
A review of measurement tests and tools to assess physical
performance and their strengths and limitations is published
elsewhere (160).
Physical activity questionnaires are often used because
they are easier to administer and can record current or
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past participation in a broad range of different sport-
ing or leisure activities, which can be classified accord-
ing to weightbearing or nonweightbearing or whether
they are muscle-strengthening activities (161, 162). Future
observational studies with bone as an outcome should
consider using bone-specific physical activity question-
naires that can take into account load characteristics (e.g.,
vertical ground reaction forces) (162–164). However, as
all self-reported questionnaires they are subject to recall
bias.
An alternative approach is to objectively measure physical
activity using devices such as pedometers and accelerome-
ters. Although there are some reports that higher pedometer-
determined activity (step counts) are associated with greater
BMD (165, 166), a limitation of these devices is that they
do not distinguish between activities of different load mag-
nitude (e.g., walking compared with jumping). In contrast,
accelerometers which can be worn at the hip or wrist and
measure acceleration [e.g., the change in speed with respect
to time (m/s) or multiplies of the acceleration of gravity
(g= 9.81m/s)] offer a unique approach to provide an estimate
of the intensity of mechanical loading of bone (167). Indeed,
previous research has shown that accelerometers can be used
to quantify the number of daily vertical impacts at different
magnitudes and loading rates (167, 168), with higher accel-
eration levels (> 3.9 g) found to be associated with increased
hip BMD (169, 170). Given the importance of moderate to
high magnitude loading to bone, observational and prospec-
tive studies should consider using accelerometers when
studying the relations between nutrition, exercise, and bone
outcomes.
Medication and supplement use
Many pharmacological agents are available for treatment
or prevention of bone-related disorders and should be
assessed in research studies. Medications can confound
diet and bone relations. The most common medications
used currently are bisphosphonates (171). After menopause,
estrogen loss induces bone loss; evaluation of any sex steroid
medications, including raloxifene, should be examined in
both women and men. Calcium and vitamin D, as well as
other micronutrient supplements, are often prescribed or
recommended to individuals at risk of poor bone health, so,
as previously mentioned, assessment of dietary supplement
use is an important parameter to include in data collection
and analysis.
With regards to medications, it is important to consider
drugs that may affect both BMD and fracture risk, and that
may also be correlated with nutritional status. For example,
selective serotonin reuptake inhibitors have been associated
with bone mass loss and increased risk of fractures. In
a recent meta-analysis, use of selective serotonin reuptake
inhibitors was significantly associated with lumbar spine
BMD reduction (154). In a recent study from NHANES,
selective serotonin reuptake inhibitor use and inadequate
daily intake of zinc was associated with low BMD (172).
Another example is antihypertensive drugs such as thi-
azides, which have been associated with less annualized
loss of BMD (156) and fractures (157). Thiazides have
been associated with hypercalcemia even when used in
combination with calcium and vitamin D among seniors
with compromised renal function or hyperparathyroidism
(158).
Other issues to consider
There are many special considerations when examining diet
and bone. First, not all nutrient effects are linear; a “satura-
tion” effect can occur with nutrients, meaning that beyond a
certain point we would not expect to see any more change
occurring in the endpoint; this has been demonstrated
with calcium and BMD (173). Similarly, U-shaped and J-
shaped risk curves may occur between the exposure and the
outcome; this has been previously described for vitamin D
andmortality (174) and for iron and osteoblast activity (175).
Thus, the expected shape of the dose-response curve can
differ with nutrients and this requires careful modeling of
the data. Second, it is well known that nutrients have a very
narrow range of effects (18), so it is of utmost importance to
take care to reduce any measurement error in exposure and
outcome so as not to attenuate what small relationsmay exist.
Third, genetic backgrounds of individuals make studying
specific effects of nutrition and bone particularly challenging.
Genetic data have been useful in our understanding of
nutrition and bone (144, 176). For assessment of gene-
diet interactions, the nutritional assessment method must
represent long-term intake. As these studies generally require
a large sample size to accommodate the comparison of
subgroups, FFQ might be the most cost-effective method
to identify relations with genes and bone (177). There
is much potential for genomewide association studies to
help advance the field, especially in interpreting diet and
bone, as reviewed elsewhere (176). Fourth, comorbidity
can substantially influence diet and bone relations. Kidney
function and renal disease modulate bone independent of
diet, and those with renal issues also tend to be on restrictive
diets. Thus, compromised kidney function is likely to be an
exclusion factor in research on nutrition and bone. Diabetes
and antidiabetic medications can alter BMD and negatively
affect bone health (178).
Discussion and Conclusions
Observational research is prime for looking at the relation
between nutrition and bone. Insights garnered from this
type of work can be used to generate hypotheses for
other types of studies, including RCTs. However, given all
of the limitations described above in measuring dietary
intakes and biomarkers, special attention to research design
and analysis is paramount to making the most strides in
observational research (Box 1). Observational research can
never demonstrate a cause and effect relation (179), but
with careful consideration of the causal criteria, it can
help address research questions for which RCT data are
lacking or questions that RCTs are not suitable to address
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(180). For example, prospective cohort or cross-sectional
data analysis can stratify based on key factors, including
nutritional status, and can be used to identify nutrition risk.
Prospective and longitudinal studies are important to study
changes in bone trajectory over time and are critical to tailor
dietary recommendations based on age and life-stage. In
research on the relation between health and nutrition, it is
important to consider association among human indicators
(e.g. health, body function, bone strength and integrity,
nutritional status, and behavior) and nutritional indicators
(nutrients such as calcium and vitamin D, food, and diet
patterns). Those indicators have a hierarchical structure
from the subordinate to the upper indicators. It is necessary
to set contexts including relation of lower indices (such
as food, diet patterns, and eating behaviors) to higher
indicators (nutrients). Therefore, selection of factors used in
observational research is an important dimension of research
in and of itself, but also for its potential to guide the design
of RCTs to help elucidate the causal role of nutritional
exposures on bone health in various life-stages. Study
design of observational research will influence the design of
RCTs, further highlighting the importance of observational
research design and methodology. Considerable research to
date has suggested that multiple nutrients, foods, and dietary
patterns are associated with bone health so this is an exciting
field and offers much promise for the future when genomic
and metabolomics data will offer new insights into diet-
microbiome-bone relations.
Box 1.
Key recommendations
 Build a multidisciplinary research team with
strengths in nutrition, bone, and research design
and statistics.
 Clearly specify the research question(s), including
primary and secondary outcomes.
 Register observational studies and research ques-
tions at clinicaltrials.gov or a similar entity before
data collection.
 Select exposure and outcome assessment methods
that address the research question.
 Select the appropriate study population and appro-
priately validated endpoints or surrogate markers.
 Determine how diet and/or nutritional status will
be operationalized. Clearly define reported or ob-
served dietary intake, biomarkers, anthropometry
measures, nutrients, dietary patterns, or intakes of
selected food groups.
 Population-specific dietary assessment tools should
be considered as a tool to aid researchers looking at
bone.
 Measure all factors related to the research using
validated methods.
 Consider multiple outcome measures to provide
verification for triangulation of assessment (i.e.,
accurately measuring all domains).
 Use biomarkers in addition to self-reported diet
when available, and validate methods with recovery
markers, predictive biomarkers, and concentration
biomarkers, as appropriate.
 Detail reporting of all the biases possible and
measures taken to reduce the bias both at the stage
of data collection and during analysis.
 Account for and document all potentially con-
founding factors and assumptions, as failure to do
this limits our ability to synthesize the research
literature with meta-analyses. This results in high
variability and dampens effect sizes for relations
between diet and health.
 Examine data carefully, examine outliers, use pur-
poseful data classification, control for multiple test-
ing, apply appropriate adjustment for confounders
and effect modifiers, employ a statistician with
nutrition experience.
 Design and implement a data-sharing plan and/or
identify a repository that other research teams can
access.
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